Study title: ACARBOSE (BAY G 5421) IN INSULIN-DEPENDENT DIABETES - THE EFFECT ON THE DAILY BLOOD-GLUCOSE PROFILE AND ON THE INSULINCONSUMPTION BY AN ARTIFICIAL PANCREAS (STUDY 0160)(PH-9873)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Nutritional and Metabolic Diseases [C18] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: ACARBOSE | |||||
ATC code: A10BF01 | |||||
Document link: Bayer Pharma_Acarbose_0160_study_synopsis.pdf | |||||
Document date: 2011-09-07 | |||||
Study number: BAY-G5421-0160 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |